Differential diagnosis of hypercalcemia in a patient with CKD G5D

Differential diagnosis of hypercalcemia in a patient with CKD G5D

Patients with chronic kidney disease are characterized by the development of mineral disorders due to a decrease in the number of functioning nephrons. These changes manifest by the development of secondary hyperparathyroidism (the overproduction of intact parathyroid hormone (PTH) associated with t...

Full description

Bibliographic Details
Main Authors:	A. K. Eremkina, A. M. Gorbacheva, D. V. Lisina, A. A. Povaliaeva, E. A. Pigarova, N. G. Mokrysheva
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2022-02-01
Series:	Ожирение и метаболизм
Subjects:	hypercalcemia secondary hyperparathyroidism renal dialysis vitamin d 24-hydroxylase ckd-mbd
Online Access:	https://www.omet-endojournals.ru/jour/article/view/12742

Similar Items

Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism
by: Paola Monciino, et al.
Published: (2022-09-01)

Risk factors and implications associated with renal mineralization in chronic kidney disease in cats
by: Pak‐Kan Tang, et al.
Published: (2022-03-01)

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
by: Cozzolino M, et al.
Published: (2017-06-01)

Optimal targets of chronic kidney disease-mineral and bone disorder markers for Chinese patients with maintenance peritoneal dialysis: a single-center retrospective cohort study
by: Xueqing Tang, et al.
Published: (2022-12-01)

Ionized hypercalcemia in cats with azotemic chronic kidney disease (2012‐2018)
by: Dirk Hendrik Nicolaas van denBroek, et al.
Published: (2022-07-01)

Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism
by: Chihiro Kato, et al.
Published: (2020-10-01)

Risk factors associated with disturbances of calcium homeostasis after initiation of a phosphate‐restricted diet in cats with chronic kidney disease
by: Pak‐Kan Tang, et al.
Published: (2021-01-01)

A rare cause of hypercalcemia presenting with high parathormone levels: Familial hypocalciuric hypercalcemia
by: Okan Bakiner, et al.
Published: (2013-08-01)

Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience
by: Orfeas Liangos, et al.
Published: (2018-08-01)

Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines
by: Jordi Bover, et al.
Published: (2023-03-01)

A case of hypercalcemia with double pathology
by: Ahmed Abdalla, et al.
Published: (2017-07-01)

Hypercalcemia in a patient with a bowing femur
by: Maroua Slouma, et al.
Published: (2021-01-01)

Severe hypercalcemia from sarcoidosis with a non-suppressed parathyroid hormone and “positive” parathyroid scan
by: Marc Cillo
Published: (2023-09-01)

Recomendaciones de la Sociedad Española de Nefrología para el manejo de las alteraciones del metabolismo óseo-mineral en los pacientes con enfermedad renal crónica: 2021 (SEN-MM)
by: José-Vicente Torregrosa, et al.
Published: (2022-12-01)

Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease
by: Ariane Zaloszyc, et al.
Published: (2023-03-01)

Aortic stenosis is a risk factor for all-cause mortality in patients on dialysis: a multicenter prospective cohort analysis
by: Daijo Inaguma, et al.
Published: (2018-04-01)

Bone Disease in Chronic Kidney Disease and Kidney Transplant
by: Ezequiel Bellorin-Font, et al.
Published: (2022-12-01)

Genetic profile of a large Spanish cohort with hypercalcemia
by: Alejandro García-Castaño, et al.
Published: (2024-03-01)

Subcutaneous calcinosis: a rare complication of chronic hypercalcemia
by: Fatima Zahra Zaher, et al.
Published: (2019-02-01)

Severe chronic kidney disease environment reduced calcium-sensing receptor expression in parathyroid glands of adenine-induced rats even without high phosphorus diet
by: Taketo Uchiyama, et al.
Published: (2020-06-01)

Challenges in the management of hypercalcemia in pregnancy – Case report of two cases
by: Shu Hui Lim, et al.
Published: (2024-03-01)

Clinical Significance of Adropin and Afamin in Evaluating Renal Function and Cardiovascular Health in the Presence of CKD-MBD Biomarkers in Chronic Kidney Disease
by: Rupinder Kaur, et al.
Published: (2023-10-01)

CKD 5D Asia—what is common and what is different from the West?
by: Kunitoshi Iseki
Published: (2018-09-01)

Prevalence and etiological profile of hypercalcemia in hospitalized adult patients and association with mortality
by: Shabna Sulaiman, et al.
Published: (2022-01-01)

Association between serum fibroblast growth factor‐23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease
by: Hirosumi Miyakawa, et al.
Published: (2021-09-01)

Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review
by: Maryam Zahedi, et al.
Published: (2021-11-01)

Diabetes due to recurrent pancreatitis secondary to hypercalcemia due to primary hyperparathyroidism
by: Sumit Kumar Chakrabarti, et al.
Published: (2013-01-01)

Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study
by: Panuccio Vincenzo, et al.
Published: (2012-10-01)

A feasibility study of avoiding positive calcium balance and parathyroid hormone increase in patients on peritoneal dialysis
by: Maria Clara Teixeira Piraciaba, et al.
Published: (2022-12-01)

Vitamin D and Diseases of Mineral Homeostasis: A <i>Cyp24a1</i> R396W Humanized Preclinical Model of Infantile Hypercalcemia Type 1
by: René St-Arnaud, et al.
Published: (2022-08-01)

Familial hypocalciuric hypercalcemia as a differential diagnosis of primary hyperparathyroidism with negative images
by: Edwin Antonio Wandurraga-Sánchez, et al.
Published: (2021-12-01)

Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease
by: Yi-Chou Hou, et al.
Published: (2022-07-01)

Identifying individuals at risk of needing CKD associated medications in a European kidney disease cohort
by: Eleni Stamellou, et al.
Published: (2024-02-01)

Familial hypocalciuric hypercalcemia: grey zones of the differential diagnosis from primary hyperparathyroidism: a case report
by: Rosaria M. Ruggeri, et al.
Published: (2021-08-01)

Effect of High Dose Active Vitamin D Therapy on the Development of Hypocalcemia After Subtotal Parathyroidectomy in Patients on Chronic Dialysis
by: Grube M, et al.
Published: (2021-11-01)

Daily calcium profile in diagnosis of hypo- and hypercalcemia in patients with chronic hypoparathyroidism. clinical case series
by: E. V. Kovaleva, et al.
Published: (2021-07-01)

Ovarian cancer presenting with hypercalcemia: two cases with similar manifestations but different mechanisms
by: Xuegong Ma, et al.
Published: (2018-06-01)

CKD-MBD: un caso “resistente”
by: Maria Polidoro
Published: (2014-11-01)

Metastatic parathyroid carcinoma: A tale of refractory hypercalcemia
by: Johns T. Johnson, et al.
Published: (2023-09-01)

Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients
by: Hisato Shima, et al.
Published: (2018-06-01)